Characterisation of Nox4 inhibitors from edible plants

Philipp A Kofler1, Haymo Pircher, Susanne von Grafenstein

  • 1Institute for Biomedical Aging Research (IBA), Austrian Academy of Sciences, Innsbruck, Austria.

Planta Medica
|January 25, 2013
PubMed

Insights

Researchers identified novel NADPH oxidase 4 inhibitors from edible plants. These compounds show efficacy comparable to existing drugs, offering a safer alternative for treating diseases linked to NADPH oxidase 4 deregulation.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Natural Products Chemistry

Background:

  • NADPH oxidases (NOX) generate reactive oxygen species (ROS) and are implicated in diseases like pulmonary fibrosis and cardiac hypertrophy.
  • NOX4 is a key target, but existing inhibitors often lack specificity or are toxic.
  • Edible plants represent a potential source for novel, safer bioactive compounds.

Purpose of the Study:

  • To discover new, specific, and non-toxic inhibitors of NADPH oxidase 4 (NOX4) from edible plant sources.
  • To characterize the inhibitory activity and specificity of identified plant-derived compounds against NOX4.
  • To explore natural products as a viable alternative to synthetic compounds for NOX4 inhibition.

Main Methods:

  • Screening of a compound library derived from edible plants for NOX4 inhibitory activity.
  • Utilizing both cell-based and cell-free assays to measure NOX4 inhibition.
  • Assessing specificity against NOX2 and NOX5, and excluding general ROS scavengers.

Main Results:

  • Several compounds from edible plants demonstrated significant NOX4 inhibitory activity.
  • Diarylheptanoids and lignans were identified as particularly effective NOX4 inhibitors.
  • The efficacy of the best plant-derived inhibitors was comparable to established pharmacological agents.

Conclusions:

  • Edible plants yield promising, specific, and potentially safer NOX4 inhibitors.
  • Diarylheptanoids and lignans represent a valuable class of natural NOX4 inhibitors.
  • These findings offer new tools for studying NOX4 inhibition and developing therapeutic strategies.